This article was originally published in Start Up
Executive SummaryPhorMax Corp. hopes to make filmless medical images affordable and widely accessible with CRView, its low-cost computed radiography system. CRView combines an imaging system and Web-based communications infrastructure to incorporate radiology images with other data in an electronic patient record, and facilitate its distribution within an institution or to interested parties on the outside. CRView will be priced at approximately $50,000, less than half the price of existing systems. And it is compatible with existing X-ray systems, which will allow imaging centers to become filmless without having to replace or reconfigure their existing equipment.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.